| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/05/2000 | US6156530 Diagnosing blood disorder in mammals; incubating blood of sensitive human with immbolized cells, monitor time for thrombosis dissolving and formation and comparing to a healthy human |
| 12/05/2000 | US6156528 Methods for using a phosphodiesterase in pharmaceutical screening to identify compounds for treatment of neoplasia |
| 12/05/2000 | US6156527 Characterizing polypeptides |
| 12/05/2000 | US6156525 Method for judging eradication of H. pylori based on rates of changes in the pepsinogen I/II ratio |
| 12/05/2000 | US6156523 Serine/threonine protein kinases |
| 12/05/2000 | US6156520 Polypeptide comprising cytokine receptor binding sequence; for utilization as a tool in genetic engineering and immunoassays |
| 12/05/2000 | US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors |
| 12/05/2000 | US6156516 Method for screening substance inhibiting activation of NF-κB |
| 12/05/2000 | US6156515 Nucleotide sequence for the detection and treatment of cancer in humans |
| 12/05/2000 | US6156514 Methods for making recombinant cells |
| 12/05/2000 | US6156513 Rna oligomer which binds to collagen gene promoter to form a triplex; antifibrotic agents for pathological fibrosis such as restenosis, atherosclerosis, liver cirrhosis, lung fibrosis, and skin fibrosis found in scleroderma |
| 12/05/2000 | US6156512 Network of nucleotide sequence of preferential size; for use in forensic analysis, heredity analysis, monitoring bone marrow transplantation, linkage mapping, and detection of genetic disorders |
| 12/05/2000 | US6156510 Polymorphisms in a microsatellite region of a glucocorticoid receptor gene |
| 12/05/2000 | US6156508 Oligonucleotide primer for strand displacement amplification of nucleotide sequences; for diagnosis, detection and amplification of microorganismal nucleotide sequences |
| 12/05/2000 | US6156507 Method of identifying methicillin-resistant Staphylococcus aureus or methicillin-resistant coagulase-negative staphylococci |
| 12/05/2000 | US6156506 Method for detecting a target substance in a sample, utilizing pyrylium compound |
| 12/05/2000 | US6156505 Specific DNA probes for the identification of the Taenia solium and Taenia saginata species |
| 12/05/2000 | US6156504 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 12/05/2000 | US6156503 Detecting human sensitivity to adrenergic stimulant; providing genomic nucleic acid sample, screening samples for alleles, classifying the human response to agonist administration |
| 12/05/2000 | US6156502 Arbitrary sequence oligonucleotide fingerprinting |
| 12/05/2000 | US6156501 Array of oligonucleotide analogue probes coupled to a solid substrate at known locations; oligonucleotides are selected to bind complementary targets with similar hybridization stability; diagnosis |
| 12/05/2000 | US6156498 Establishment of HHV-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting HHV-8 infection |
| 12/05/2000 | US6156496 Suppressing microorganism propagation in eukaryotic cell; administering a blocking agent to cells to prevent suppression of kinase activity |
| 12/05/2000 | US6156495 Kit for detecting the presence of microorganism antigen in humans; for the development of vaccines against viral diseases |
| 12/05/2000 | US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 12/05/2000 | US6156338 Method for preparing compositions for transferring nucleic acids |
| 12/05/2000 | US6156310 Isolated polypeptide |
| 12/05/2000 | US6156178 Increased throughput analysis of small compounds using multiple temporally spaced injections |
| 12/05/2000 | US6156173 Enzyme electrode structure |
| 12/05/2000 | CA2203545C Amplification and detection of mycobacterium avium complex species |
| 12/05/2000 | CA2200702C Lyophilized bioluminescent bacterial reagent for the detection of toxicants |
| 12/05/2000 | CA2200347C Detection of hydrophobic amplification products by extraction into an organic phase |
| 12/05/2000 | CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
| 12/05/2000 | CA2037963C Device for ligand receptor methods |
| 12/05/2000 | CA2000596C Chromogenic merocyanine enzyme substrates |
| 12/04/2000 | CA2288531A1 A method for diagnosing astrocytic tumors by detecting chromosomal aberration |
| 11/30/2000 | WO2000072258A2 Method and system for general purpose analysis of experimental data |
| 11/30/2000 | WO2000072022A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 11/30/2000 | WO2000072021A2 Cancer associated antigens and uses therefor |
| 11/30/2000 | WO2000072019A2 Liposome-enhanced test device and method |
| 11/30/2000 | WO2000072018A1 Method for the identification and/or the quantification of a target compound |
| 11/30/2000 | WO2000072016A1 Fluorescence polarization assays involving polyions |
| 11/30/2000 | WO2000072015A2 Diagnostics and therapeutics for cardiovascular disorders |
| 11/30/2000 | WO2000072011A1 Method for assaying phosphorylation enzyme activity |
| 11/30/2000 | WO2000072008A2 Identification of novel mechanisms of drug resistance |
| 11/30/2000 | WO2000071999A1 Device and method for isolating electrically charged molecules |
| 11/30/2000 | WO2000071987A2 Isolation and culturing of fetal cells |
| 11/30/2000 | WO2000071757A1 Compositions and methods for labeling of nucleic acid molecules |
| 11/30/2000 | WO2000071756A2 Mathematical analysis for the estimation of changes in the level of gene expression |
| 11/30/2000 | WO2000071755A2 Method for sequency and characterizing polymeric biomolecules using aptamers and a method for producing aptamers |
| 11/30/2000 | WO2000071754A1 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
| 11/30/2000 | WO2000071753A2 Diagnostics and therapeutics for restenosis |
| 11/30/2000 | WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors |
| 11/30/2000 | WO2000071751A1 Diabetes gene |
| 11/30/2000 | WO2000071750A1 Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method |
| 11/30/2000 | WO2000071749A2 Detection system for analyzing molecular interactions, production and utilization thereof |
| 11/30/2000 | WO2000071748A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 11/30/2000 | WO2000071747A2 Detection system for separating constituents of a sample and production and use of the same |
| 11/30/2000 | WO2000071745A1 Method for passively determining the application of a sample fluid on an analyte strip |
| 11/30/2000 | WO2000071744A1 FmhB-PROTEIN AND MODULATORS OF THIS PROTEIN |
| 11/30/2000 | WO2000071742A2 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics |
| 11/30/2000 | WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 11/30/2000 | WO2000071729A2 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 11/30/2000 | WO2000071728A1 Recombinant bacterial phytases and uses thereof |
| 11/30/2000 | WO2000071710A2 Expression products of genes involved in diseases related to cholesterol metabolism |
| 11/30/2000 | WO2000071707A1 A method for the diagnosis and treatment of cancer and agents useful therefor |
| 11/30/2000 | WO2000071705A1 Novel psychrotrophic bacterium and dna probe for detecting the bacterium |
| 11/30/2000 | WO2000071703A2 Inhibition of histone deacetylase |
| 11/30/2000 | WO2000071702A1 Interaction-activated proteins |
| 11/30/2000 | WO2000071700A1 Methods for separating, fractionating and analyzing gene of virus existing in water |
| 11/30/2000 | WO2000071698A2 Mixture for neutralizing enzyme inhibitors |
| 11/30/2000 | WO2000071693A2 Method for selecting improved vectors |
| 11/30/2000 | WO2000071682A2 Crystal structure data of cysteinprotease gingipain r |
| 11/30/2000 | WO2000071681A1 A polynucleotide motor, a motor system, their preparation and uses |
| 11/30/2000 | WO2000071679A2 Human oxidoreductase proteins |
| 11/30/2000 | WO2000071677A1 Method for providing a substrate structure for oriented neurite outgrowth, substrate structure, and device for monitoring neurons |
| 11/30/2000 | WO2000071675A1 Method for rapidly detecting and enumerating microorganisms in mammalian cell preparations using atp bioluminescence |
| 11/30/2000 | WO2000071674A1 Simple culture medium and method for preparation thereof |
| 11/30/2000 | WO2000071670A2 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 11/30/2000 | WO2000071668A2 Method for identifying components involved in signal transduction pathways in higher plants |
| 11/30/2000 | WO2000071584A1 Seven transmembrane receptor genes |
| 11/30/2000 | WO2000071575A1 Models of prion disease |
| 11/30/2000 | WO2000071566A2 Novel organic anion transport proteins |
| 11/30/2000 | WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 11/30/2000 | WO2000071562A1 High specificity primers, amplification methods and kits |
| 11/30/2000 | WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 11/30/2000 | WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes |
| 11/30/2000 | WO2000071167A1 Method for evaluating matrix metalloprotease inhibitory activity |
| 11/30/2000 | WO2000071161A1 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferative drugs |
| 11/30/2000 | WO2000071158A1 Tagged epitope protein transposable element |
| 11/30/2000 | WO2000071081A2 Methods of diagnosis and treatment of meniere disease |
| 11/30/2000 | WO2000071080A2 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 11/30/2000 | WO2000050607A3 Goodpasture antigen binding protein |
| 11/30/2000 | WO2000047761A3 High-throughput toxicological testing using cultured organisms and cells |
| 11/30/2000 | WO2000047760A3 Atm kinase modulation for screening and therapies |
| 11/30/2000 | WO2000047750A3 Metalloproteases of the neprilysin family |
| 11/30/2000 | WO2000047739A3 Autoantigens for the diagnostic of endometriosis |
| 11/30/2000 | WO2000047738A3 Human and mouse trek-1 potassium channel protein and their use |
| 11/30/2000 | WO2000047615A3 Proteins related to neuronal regeneration and uses thereof |
| 11/30/2000 | WO2000046839A3 LUMINESCENCE SPECTRAL PROPERTIES OF CdS NANOPARTICLES |